CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
We need your help
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
Your support makes The Advocate's original LGBTQ+ reporting possible. Become a member today to help us continue this work.
The Food and Drug Administration on Wednesday approved the ViroSeq HIV-1 Genotyping System, developed by Celera Diagnostics, for the detection of mutations in HIV's viral genome that convey resistance to anti-HIV medications. "We believe the ViroSeq HIV-1 Genotyping System can be a valuable tool for physicians seeking the best course of treatment for HIV-infected individuals," said Celera president Kathy Ordonez. "While HIV genotyping has become routine practice in the selection of drug therapy regimens to fight this disease, testing methods have yet to become standardized. The ViroSeq system, with its combination of FDA-cleared algorithms and reagents, has the potential to become a standard among clinical testing laboratories." The tests will be manufactured by Celera and distributed by Abbott Diagnostics.
From our Sponsors
Most Popular
Watch Now: Pride Today
Latest Stories
Appeals court rules transgender Florida teacher cannot use female pronouns in school
July 04 2025 7:00 AM
How dark will our skies be on July 4, 2026?
July 04 2025 6:00 AM
Queer subtext in Disney's 'Elio' was reportedly cut by Pixar
July 03 2025 12:30 PM
BREAKING: Supreme Court to decide whether states can ban transgender women & girls from sports
July 03 2025 10:02 AM
True
Who was Jimmy Swaggart, the late, anti-LGBTQ+, disgraced televangelist?
July 02 2025 5:40 PM
Wisconsin Supreme Court strikes down abortion ban from 1849
July 02 2025 11:55 AM
The deadly 'big beautiful' budget bill will turn America into a morgue
July 02 2025 11:28 AM